Improving organoid analysis with new developmental approaches
Having gained experience developing patient-derived organoids during her postdoc training and quickly identifying them as an hot prospect for the life sciences, Alice Soragni (left) founded her lab at the University of California, Los Angeles (UCLA; CA, USA) with a mission statement focused to develop sophisticated organoid models for cancer research. Now her lab includes a basic research line focused on protein aggregation in cancer, which runs alongside her investigations of tumor organoid models for rare cancers. Here, we discuss her work on the development of tumor organoid models for benign conditions and rare malignant cancers, how she has altered...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!